Connect with us


3 TSX Stocks Under $10 That Could Double Your Money



The Canadian stock market has recovered strongly from its March lows. Currently, the S&P/TSX Composite Index trades just 2.7% lower for this year. Despite the strong recovery, few stocks are still trading at a fair valuation and provide excellent buying opportunities. In this article, we will be focusing on three companies that are trading under $10 and have the potential to double your investments in the next three years.


My first pick is a cannabis company Hexo (TSX:HEXO)(NYSE:HEXO), which has lost over 55% of its stock value this year. However, in its recently reported third-quarter earnings, the company outperformed analysts’ sales expectations. Its revenue grew 30% on a sequential basis to $30.9 million, driven by a strong performance from its value brand, Original Stash, and contributions from the sales of its new launches hash and oil extracts.

Meanwhile, in July, the company expanded the availability of its vape product lines in both medical and recreational segments across Canada. Earlier, it had received the approval to expand its cannabis manufacturing and processing facility in Belleville to include the beverage production facility. Also, the company recently launched its medical cannabis products in Israel. All these initiatives could boost the company’s sales in the foreseeable future.

Although HEXO’s adjusted EBITDA showed an improvement in its recently reported quarter, it was still in the negative territory. However, the company is working on reducing its expenditures and improving its operational efficiency to move toward profitability. It has reduced its workforce, sold excess assets, and has automated the packaging activities.

HEXO’s management is hopeful of reporting positive EBITDA by the first half of fiscal 2021. So, given the healthy sales outlook and improving margins, I believe HEXO stock could double over the next three years.


My second pick is a technology company BlackBerry (TSX:BB)(NYSE:BB). It provides security software solutions to companies across various sectors, including automotive, medical, and industrial automation. Currently, the company trades 23% lower for this year due to the disruption caused by the pandemic in its end markets, primarily the automotive sector.

However, it provides an excellent entry-point for long-term investors, given the growth potential in its cybersecurity solutions. Amid the pandemic, many businesses have taken their shops online. Also, an increased number of employees are working from their homes.

So, these operational shifts have increased the demand for data safety and privacy solutions, thus benefiting BlackBerry. Meanwhile, with the reopening of the economies across the world, the automotive sector is also gradually recovering.

At the end of the first quarter, the company’s cash, cash equivalents, and investments stood at US$955 million. Further, management expects to generate positive free cash flow in this fiscal. So, the company is well positioned to ride out this crisis. Also, given its strong growth prospects, attractive valuation, and stable balance sheet, I am bullish on BlackBerry.

StorageVault Canada

My third pick is StorageVault Canada (TSXV:SVI), which owns, operates, and leases over eight million square feet of storage spaces. Despite the impact of the pandemic, the company’s revenue grew over 3% in its recently announced second quarter. Its adjusted funds from operations were 14.8% higher compared to its previous year’s quarter.

The Canadian storage market is estimated to be at 90 million square feet spread across 2,500 stores. Meanwhile, the top 10 Canadian companies own less than 15% of these stores, indicating the sector is highly fragmented and provides an opportunity for inorganic growth. In 2019, StorageVault Canada had acquired 46 stores for $373 million. For this year, the company expects to acquire assets in the range of $50 million to $75 million.

The threat of the pandemic still looms large. So, many businesses impacted by the outbreak could vacate their rental space by moving their items to storage to cut down on their rental expenses. Thus, both the near-term and long-term growth potential of the company looks strong. With the company currently trading at 20% lower for this year, it provides an excellent entry-point for long-term investors.

Source:- The Motley Fool Canada

Source link


Goldman Sachs moves to full ownership of China securities JV



Goldman Sachs said on Sunday it received approval from China’s securities regulator to take full control of its mainland securities business.

The U.S. bank said it would buy the remainder of Goldman Sachs Gao Hua Securities Company Ltd (GSGH), and rename it as Goldman Sachs (China) Securities Company Ltd.

The migration of its onshore business units to GSGH from Beijing Gao Hua Securities was underway, it added.

“This marks the start of a new chapter for our China business following a successful 17-year joint venture,” Goldman Sachs said in a statement.

It becomes the second Wall Street firm to be granted approval to shift to full ownership of its securities business after JPMorgan Chase & Co moved to 100% in August

Securities businesses in China typically house investment banking, research, equities and fixed income businesses.

Unlike most of the other China JVs, Goldman had day-to-day operational control of its business even with its minority ownership.

Lucrative underwriting fees on equity and bond transactions – especially initial public offerings (IPOs) – in China’s expanding capital markets has been the driving force for Western banks to increase stakes in their mainland business.

Full ownership could allow foreign banks to expand their operations in the multi-trillion-dollar Chinese financial sector, and better integrate them with their global businesses.

Morgan Stanley currently owns 90% of its securities joint venture with partner Shanghai Chinafortune Co Ltd after increasing its stake in May.

China’s regulators had examined Goldman Sach’s application to move to full ownership since the bank flagged its intention to buy out its partner in December.

(Reporting by Scott Murdoch in Hong Kong and Nikhil Kurian Nainan in Bengaluru; editing by Uttaresh.V and Stephen Coates)

Continue Reading


From Canada? Want to go to the U.S.A.? Better have the right vaccine – Boing Boing



The last couple of years have been hard on Canadian Snowbirds. Many of us, myself included, are used to heading south in the fall, to escape the icy bullshit of a Canadian winter. Unfortunately, thanks to COVID-19, a lot of us have been trapped, north of the wall, since March 2020. 

I’ve been fine with this. 

When the land border was closed down to everyone but essential travellers, my mindset was that if I was going to get sick, I’d just as soon do it in my own nation where healthcare is free (yeah, we pay our taxes, but still.) Then, last winter, the vaccines started to roll out. By early spring, both my wife and I had been injected with two doses of Pfizer’s version of the brew. We breathed a sigh of relief and began to hope that we might, one day soon, be able to start our travels again. I’m sure that lots of other folks did too. Unfortunately, depending on where in Canada they live, it wasn’t a sure bet that they’d wind up with two doses of the same vaccine. In the rush to get as many Canadians vaccinated against the plague as possible, many provinces started mixing and matching whichever vaccines that they had on hand.

So, you could wind up with Pfizer for your first jab and Moderna for your second. It’s cool, they told us. Mixing vaccines affords tons of protection, we were assured. Why, we’d all be able to get back to our lives in no time… provided said life doesn’t include travelling to one of many countries where vaccine mixing is considered to be a dangerous load of bullshit. You may have guessed by now, that America is one of those countries.  

From The CBC:

…at the same time the U.S. reopens the land border, it will start requiring that foreign land and air travellers entering the country be fully vaccinated.

The U.S. Centers for Disease Control (CDC) currently doesn’t recognize mixed COVID-19 vaccines — such as one dose of AstraZeneca, and one dose of Pfizer or Moderna — and hasn’t yet said if travellers with two different doses will be blocked from entry when the vaccine requirement kicks in.

So that sucks. 

According to the CBC, the Centers for Disease Control and Prevention might soon consider changing their stance on mixed vaccines. I’d like to think that a crap load of data on the effectiveness of mixed vaccine dosing will play into such a decision. No matter how badly folks might want to head south for the winter, Americans deserve to be as safe as they can be. 

In the meantime, I suspect that, just like last fall, many snowbirds will wind up on Vancouver Island, where I hang my hat, these days. It’s warm enough here that living in an RV is both possible and comfortable.

But I’ll tell ya, it’s a far cry from kicking back in the trade winds on the cusp of Texas’ southern border.

Image via Wikipedia Commons

Adblock test (Why?)

Source link

Continue Reading


Travel industry, health experts applaud U.S. decision to allow travellers with mixed doses – CTV News



The organization representing Canada’s tourism industry is applauding the U.S. government’s decision to allow Canadian travellers with mixed vaccine doses once the border opens in November.

On Friday, the U.S. Centers for Disease Control and Prevention confirmed that travellers with “any combination” of two doses of vaccines approved by the World Health Organization or the U.S. Food and Drug Administration “are considered fully vaccinated.”

Beth Potter, who is president and CEO of the Tourism Industry Association of Canada, says the announcement is “really good news.”

“What it does is it provides a little bit more clarity, and this is something that we’ve talked about a lot. We know now that if you’ve got that mixed dose, as of November you’re going to be able to enter into the United States,” she told CTV News Channel on Saturday.

Infectious disease expert Isaac Bogoch of the University Health Network in Toronto says allowing mixed dosed travellers is “a smart and data driven approach.”

“This will be a huge relief to many Canadians who did the right thing and got vaccinated and even took those mixed and matched vaccine approaches. It’s safe, it’s effective, and now there’s a recognition of this,” Bogoch said in an interview with CTV News Channel on Saturday.

“I’m really happy to hear this. It’s about time.”

This announcement came after the White House confirmed that the U.S. land borders with Canada and Mexico would be open to fully vaccinated tourists by Nov. 8.

On the American side, the U.S. Travel Association also applauded the Biden Administration’s plans to reopen the border.

“Reopening to international visitors will provide a jolt to the economy and accelerate the return of travel-related jobs that were lost due to travel restrictions,” said association president and CEO Roger Dow in a statement on Friday.

“We applaud the administration for recognizing the value of international travel to our economy and our country, and for working to safely reopen our borders and reconnect America to the world.”

But while the U.S. won’t require Canadians to show proof of vaccination to cross, returning to Canada requires a negative PCR test conducted at most 72 hours before crossing the border.

PCR tests can cost upwards of $200. The Canadian government does not accept rapid antigen tests, which can be had for only $40.

Brian Higgins, a New York congressman whose district includes the border cities of Buffalo and Niagara Falls, wants to see Canada drop the COVID-19 PCR test requirement.

“I think that the U.S. decision to allow Canadians coming into the United States without a test again underscores the potency of the vaccine,” Higgins told The Canadian Press on Friday. “I would like to see that reciprocated by our Canadian neighbours.”

However, Public Safety Minister Bill Blair said that Canada will continue to require PCR tests so long as the Public Health Agency of Canada advocates for it.

“We’ve seen throughout the pandemic that advice has evolved as new evidence and new data is available. We’ll continue to follow the advice in the Public Health Agency Canada​,” he said in an ​interview with CTV’s Question Period on Sunday.

Adblock test (Why?)

Source link

Continue Reading